zacks.com / .zacks-com / Page 3

Shares of ProKidney jump 515% after its kidney cell therapy shows strong efficacy in a Phase II diabetes-related CKD study.

KO posts 6% organic growth as strong global momentum offsets flat North America volumes and shifting consumer sentiment.

Although Apple iPhone recovers some ground in China, stiff competition and stretched valuation make the stock a risky bet for investors.

VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.

Applied Materials gains from booming AI demand, with traction across its foundry, logic and DRAM offerings.

Fortinet beats Check Point with superior growth momentum, stronger SASE positioning, and firewall refresh catalysts.

PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.

SUBCY wins a $50-$150 million subsea contract offshore Egypt, expanding its project footprint with strategic new work in the region.

SOUN is up 55% in three months, driven by booming AI revenue. Can it keep climbing despite high valuation and losses?

BBAI surges 101% in a month as it secures key defense AI contracts and eyes growth despite widening EBITDA losses.